PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Jun-2025 Orthokeratology Market to Reach USD 659.1 Million by 2034 at 4.8% CAGR MARKITWIRED
04-Jun-2025 NanoViricides Measles Drug Development Animal Study is Imminent ACCESS Newswire
04-Jun-2025 Evolva Holding SA Takes Note of GZO Shareholder Communities’ Announcementv Evolva Holding SA
04-Jun-2025 AlzeCure Pharma to present at Redeye Investor Forum on June 11 ACCESS Newswire
04-Jun-2025 Jet Biofil and LabCart Leverage Bioz Badges to Highlight the Importance of Publication Content in Driving Product Visibility and Website Engagement ACCESS Newswire
04-Jun-2025 BioInvent Presents at PAGE 2025 a Poster Highlighting Model-Informed Early Clinical Development of Anti-TNFR2 Drug Candidate BI-1910 ACCESS Newswire
04-Jun-2025 IRLAB Participates in Aktiespararna’s Event - Aktiedagarna ACCESS Newswire
03-Jun-2025 Astoriom Expands Global Footprint for Sample Stability Storage Services Astoriom
03-Jun-2025 European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD Takeda
03-Jun-2025 Industry Leading RBQM Event Returns for 2025 CluePoints
03-Jun-2025 Evotec SE: Results of the Annual General Meeting 2025 Evotec SE
03-Jun-2025 Biotest AG: Delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6 June 2025 Biotest AG
03-Jun-2025 Amber Implants Announces Successful One-Year Follow-Up Data in First-in-Human Clinical Trial of VCFix® Spinal System Amber Implants
03-Jun-2025 Simris Group AB Signs Non-Binding Concept Sheet for Potential Antibody-Drug Conjugate Collaboration Simris Group
03-Jun-2025 Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test Biocartis
03-Jun-2025 Qlucore Releases New Version of Qlucore Omics Explorer in the Cloud Qlucore
03-Jun-2025 ASCO: new Sarclisa data support subcutaneous administration with on-body injector Sanofi
03-Jun-2025 NICE recommends once-weekly Sogroya®▼ (somapacitan injection) as treatment for growth failure caused by growth hormone deficiency in people aged 3 to 17 years Novo Nordisk
03-Jun-2025 CenExel Appoints Samantha Stellenberg as Interim Chief Operating Officer at Site in Atlanta, GA Newswire
03-Jun-2025 Infineon Technologies Partners With the Healthcare Impact Alliance to Power Next Generation of Connected Senior Care Solutions ACCESS Newswire